Results 191 to 200 of about 939,476 (345)

Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Endovascular treatment (EVT) achieves high rates of recanalization in acute large‐vessel occlusion (LVO) stroke, but functional recovery remains heterogeneous. While symptomatic intracranial hemorrhage (sICH) has been well studied, the prognostic impact of asymptomatic intracranial hemorrhage (aICH) after EVT is less certain ...
Shihai Yang, Chengsong Yue, Zhuang Li, Xiaolei Shi, Haoxuan Zhu, Jie Yang, Linyu Li, Jiaxing Song, Shitao Fan, Gaoming Li, Wenzhe Sun, Zhixian Ye, Jiacheng Huang, Dahong Yang, Jinfu Ma, Xu Xu, Zhixi Wang, Lilan Wang, Guojian Liu, Fengli Li, Changwei Guo, Li Qi, Wenjie Zi   +22 more
wiley   +1 more source

Engagement in Advance Care Planning and Surrogates’ Knowledge of Patients’ Treatment Goals

, 2017
Terri R. Fried, Maria Zenoni, Lynne Iannone, John R. O’Leary, Brenda T. Fenton   +4 more
openalex   +2 more sources

‘Evaluating an Advance Care Planning Curriculum: a Lecture, a Game, a Patient, and an Essay’—a medical student’s perspective [PDF]

, 2019
Emma Mittelman, Rebecca A. Clark
openalex   +1 more source

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

Arthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

OP01 Volunteer-led advance care planning advisory and education services: an evaluation of a new model for australian service delivery [PDF]

, 2019
H Kelly, Linda Nolte, Audrey R. Verde, Karen Detering   +3 more
openalex   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Special care dentistry: Advanced care planning [PDF]

British Dental Journal, 2018
openaire   +2 more sources

Measuring Advance Care Planning: Optimizing the Advance Care Planning Engagement Survey (TH307C) [PDF]

, 2017
Rebecca L. Sudore, Daren K. Heyland, Deborah E. Barnes, Michelle Howard, Konrad Fassbender, Carole A. Robinson, John Boscardin, John J. You   +7 more
openalex   +1 more source

87 Priorities for future care: advance care planning for nursing home residents [PDF]

, 2020
Jessica Walding, Siwan Seaman
openalex   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source